Company Analysis

Enanta Pharmaceuticals, Inc. (ENTA)

Nasdaq: ENTA · Pharmaceutical Preparations · Watertown, MA · filing with the SEC since 2002
Grade5.2
◀ Past 5.6● Present 5.0▶ Future 5.1
1 est.

Who runs Enanta Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Luly Jay R.
President and CEO. First filing Mar 2013, latest Feb 13, 2026, 9 filings in all.
Officers reporting now
8
of 14 people with a filing in the last fifteen months
Directors reporting now
6
21 people on the record since 2013
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rottinghaus Scott T.Chief Medical OfficerAug 2022Aug 10, 20261 · $0.00
Luly Jay R.President and CEOMar 2013Feb 13, 20261 · $100,000
Kieffer Tara LynnChief Product Strategy OfficerDec 2020Feb 13, 20261 · $0.00
Kowalsky Matthew PaulChief Legal OfficerMay 2024Feb 13, 2026none
Luu BrendanChief Business OfficerJan 2021Feb 13, 20261 · $0.00
Or Yat SunChief Scientific OfficerMar 2013Feb 13, 20261 · $0.00
Trout Harry R. IIIVice President, Finance (Principal Financial Officer)Sep 2025Dec 5, 20252 · $0.00
Capps Kathleen S.Executive Director of Accounting, Controller (Principal Accounting Officer)Sep 2025Dec 5, 20252 · $0.00
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Carter Bruce L AdirectorDec 2013Mar 13, 2026none
Foletta Mark GdirectorJul 2020Mar 13, 2026none
Hata Yujiro SdirectorAug 2021Mar 13, 2026none
Peterson KristinedirectorSep 2017Mar 13, 2026none
Russell LesleydirectorNov 2016Mar 13, 2026none
Vance TerrydirectorMar 2013Mar 13, 2026none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ENTA · research, not advice